FAKTOR-OPTIONSSCHEIN - INMODE Share Price

Certificat

DE000MG31LB7

Real-time Bid/Ask 04:55:44 13/06/2024 pm IST
7.55 EUR / 7.75 EUR +2.55% Intraday chart for FAKTOR-OPTIONSSCHEIN - INMODE
Current month+3.18%
1 month-11.92%
Date Price Change
13/24/13 7.32 -1.88%
12/24/12 7.46 -1.06%
11/24/11 7.54 +2.31%
10/24/10 7.37 -2.25%
07/24/07 7.54 -0.66%

Delayed Quote Börse Stuttgart

Last update June 13, 2024 at 03:16 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying INMODE LTD.
Issuer Morgan Stanley
WKN MG31LB
ISINDE000MG31LB7
Date issued 25/04/2024
Strike 24.44 $
Maturity Unlimited
Parity 0.74 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.81
Lowest since issue 6.41
Spread 0.2
Spread %2.58%

Company Profile

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Sector
-
More about the company

Ratings for InMode Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: InMode Ltd.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
18.33 USD
Average target price
25.6 USD
Spread / Average Target
+39.66%
Consensus